China News Service, Beijing, September 14th. September 14th is World Atopic Dermatitis Day. Professor Zhang Jianzhong, director of the Department of Dermatology of Peking University People's Hospital, hosted by the Dermatology Rehabilitation Professional Committee of the Chinese Association of Rehabilitation Medicine, led more than 20 authoritative experts in the field of dermatology. , jointly released "Top Ten Hot Topics Concerning Atopic Dermatitis Patients".
The ten hot topics are based on the "100 Questions and Answers Project for Chinese Atopic Dermatitis Patients", which aims to further enhance patients' awareness of standardized diagnosis and treatment and long-term management, call on more people to pay attention to and understand atopic dermatitis, and promote atopic dermatitis in my country Standardized diagnosis and treatment of sexual dermatitis and improvement of long-term management system.
At the same time, the "AD-Talk: Seeing the New Story" forum was also held online on the same day. Doctors and patients shared real diagnosis and treatment stories on the same stage. Through disease popularization and the voices of doctors and patients, they helped improve the level of skin health diagnosis and treatment for the whole people.
As a type 2 inflammatory disease, atopic dermatitis is the "No. 1 disease" in dermatology, with three characteristics of chronic, inflammatory and recurrent.
Chronic eczema-like skin lesions and repeated itching brought about by atopic dermatitis have brought serious physical, psychological and life burdens to patients. Type 2 inflammatory comorbidities such as rhinitis and asthma may follow, resulting in "one disease" becoming "multiple diseases".
Zhang Jianzhong said that in terms of the Chinese population, for every 100 children, there are 10 to 15 patients with atopic dermatitis; for every 100 adults, there are 2 to 8 patients with atopic dermatitis.
However, there are still many patients or their parents who are unaware of the disease.
To this end, Zhang Jianzhong led a team of more than 20 authoritative experts in the fields of dermatology and allergy across the country to participate in the compilation and release of "100 Questions and Answers for Chinese Atopic Dermatitis Patients".
Among them, the "Top Ten Hot Topics Most Concerned by Patients with Atopic Dermatitis" emerged as the times require, reflecting the major skin health problems that patients are most worried about, involving disease cognition and harm, treatment and nursing.
Through the expert's easy-to-understand answers, it helps patients understand popular science knowledge and builds the first layer of "armor" for patients.
Zhang Jianzhong expressed the hope that the release of these ten hot topics will make patients pay more attention to the standardized diagnosis and treatment of the disease and strengthen long-term management, and also help the public get closer to and understand atopic dermatitis.
The full version of "100 Questions and 100 Answers" has been launched on the official account of AD Home in China, and the paper version will also be distributed in major hospitals across the country.
"We hope that through our practical actions, we will gather more forces to promote the improvement of the level of atopic dermatitis diagnosis and treatment and benefit Chinese patients."
Benefiting from the development of modern medicine and the advancement of science and technology, atopic dermatitis is no longer at the mercy of clinicians as in the past.
Zhang Jianzhong said that in the past, in the face of atopic dermatitis, dermatologists often had the embarrassment of "a clever woman can't cook without rice".
Innovative treatment methods continue to arrive with breakthroughs in science and technology, becoming the hope of patients.
Among them, the mechanism of biological agents is the core of targeting type 2 inflammatory response. With innovative therapies that accurately block the inflammatory process without suppressing the immune system on a large scale, patients are more confident and their cooperation with doctors is also higher.
At the "AD-Talk: Seeing the New Life Story" forum, a number of authoritative celebrities came to the stage and talked about the atopic dermatitis patients they encountered in the outpatient clinic in the past few years, sharing their stories and passing on popular science knowledge.
As a chronic inflammatory disease, atopic dermatitis is especially "favored" for children and adolescents, and it will recur, which not only affects the growth and development of children and physical and mental health, but also seriously affects the quality of life of children and the entire family.
Ma Lin, director of the Department of Dermatology at Beijing Children's Hospital Affiliated to Capital Medical University, National Children's Medical Center, said: "If a child does not sleep, the whole family will not sleep; if a child is noisy, the whole family will not be at peace. In my outpatient clinic, the common phenomenon is that parents are anxious and children are uneasy. Unhappy, they all need to pass the 'psychological checkpoint' and 'safety checkpoint'. During the outpatient clinic, I often spend an hour to relieve the nervousness and anxiety of the children and parents, and at the same time tell them to pay attention to medication safety And trust the doctor and hand over the problem to the doctor. For pediatric patients, safety is always the doctor's first consideration, especially for diseases such as atopic dermatitis that require long-term treatment, treatment must be comprehensively considered from a long-term perspective safety, efficacy, and long-term treatment costs.”
Aiming at the pathogenesis of type 2 inflammation of atopic dermatitis, precise targeted therapy not only allows patients to subside dermatitis and relieve itching, but also reduce the risk of possible accompanying comorbidities such as allergic rhinitis and asthma.
Wang Xiaoyang, deputy chief physician of the Department of Dermatology and Venereology of Beijing Anzhen Hospital, said that atopic dermatitis, allergic rhinitis, asthma and a series of comorbidities all belong to type 2 inflammatory diseases.
Modern scientific research has shown that they share common inflammatory pathways, such as interleukin 4 (IL-4) and interleukin 13 (IL-13).
If the human body is compared to a big tree, when the inflammation gathers to the trunk and cuts it off, it will no longer be "blooming", blocking the type 2 inflammation pathway, and it will relieve the symptoms of inflammation in the whole body.
It not only solves the unbearable itching, but also effectively relieves and long-term control of rhinitis, asthma and other discomforts, so that patients can live and work without interference.
"In the outpatient clinic, I often meet patients who wake up with itching in the early morning, and becoming an "ordinary person" is their most urgent desire." said Yao Xu, director of the Department of Allergy and Rheumatism and Immunology, Dermatology Hospital, Chinese Academy of Medical Sciences. , "For them, the process of becoming an 'ordinary person' is difficult. After all, this is a chronic disease, and it is impossible to completely cure it with one or two treatments. But as long as we join forces and work together, we can manage and regulate them for a long time. With treatment, the vast majority of patients can control the disease to the greatest extent, reduce recurrence, fall asleep like a 'normal person' with the night, and wake up in the morning sun like an 'ordinary person'." (End)